A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
Clinical trial NCT05784441 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05784441
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-06
- Primary completion
- 2027-01-06
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.